160 related articles for article (PubMed ID: 11966455)
1. New trends in dual 5-LOX/COX inhibition.
Leval Xd; Julemont F; Delarge J; Pirotte B; Dogne JM
Curr Med Chem; 2002 May; 9(9):941-62. PubMed ID: 11966455
[TBL] [Abstract][Full Text] [Related]
2. Recent development in the field of dual COX / 5-LOX inhibitors.
Julémont F; Dogné JM; Pirotte B; de Leval X
Mini Rev Med Chem; 2004 Aug; 4(6):633-8. PubMed ID: 15279597
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept.
Celotti F; Laufer S
Pharmacol Res; 2001 May; 43(5):429-36. PubMed ID: 11394934
[TBL] [Abstract][Full Text] [Related]
4. Dual acting anti-inflammatory drugs.
Leone S; Ottani A; Bertolini A
Curr Top Med Chem; 2007; 7(3):265-75. PubMed ID: 17305569
[TBL] [Abstract][Full Text] [Related]
5. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
6. Novel N-substituted 5-aminosalicylamides as dual inhibitors of cyclooxygenase and 5-lipoxygenase enzymes: Synthesis, biological evaluation and docking study.
El-Nagar MKS; Abdu-Allah HHM; Salem OIA; Kafafy AN; Farghaly HSM
Bioorg Chem; 2018 Aug; 78():80-93. PubMed ID: 29550533
[TBL] [Abstract][Full Text] [Related]
7. Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy?
Fiorucci S; Meli R; Bucci M; Cirino G
Biochem Pharmacol; 2001 Dec; 62(11):1433-8. PubMed ID: 11728379
[TBL] [Abstract][Full Text] [Related]
8. Regulation of COX and LOX by curcumin.
Rao CV
Adv Exp Med Biol; 2007; 595():213-26. PubMed ID: 17569213
[TBL] [Abstract][Full Text] [Related]
9. Prevention of thrombosis and vascular inflammation: benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors.
de Gaetano G; Donati MB; Cerletti C
Trends Pharmacol Sci; 2003 May; 24(5):245-52. PubMed ID: 12767724
[TBL] [Abstract][Full Text] [Related]
10. Safer anti-inflammatory therapy through dual COX-2/5-LOX inhibitors: A structure-based approach.
P JJ; Manju SL; Ethiraj KR; Elias G
Eur J Pharm Sci; 2018 Aug; 121():356-381. PubMed ID: 29883727
[TBL] [Abstract][Full Text] [Related]
11. Chebulagic acid, a COX-LOX dual inhibitor isolated from the fruits of Terminalia chebula Retz., induces apoptosis in COLO-205 cell line.
Reddy DB; Reddy TC; Jyotsna G; Sharan S; Priya N; Lakshmipathi V; Reddanna P
J Ethnopharmacol; 2009 Jul; 124(3):506-12. PubMed ID: 19481594
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of some novel indolizine derivatives as dual cyclooxygenase and lipoxygenase inhibitor for anti-inflammatory activity.
Shrivastava SK; Srivastava P; Bandresh R; Tripathi PN; Tripathi A
Bioorg Med Chem; 2017 Aug; 25(16):4424-4432. PubMed ID: 28669741
[TBL] [Abstract][Full Text] [Related]
13. Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition.
Geronikaki AA; Lagunin AA; Hadjipavlou-Litina DI; Eleftheriou PT; Filimonov DA; Poroikov VV; Alam I; Saxena AK
J Med Chem; 2008 Mar; 51(6):1601-9. PubMed ID: 18311898
[TBL] [Abstract][Full Text] [Related]
14. New hybrid molecules combining benzothiophene or benzofuran with rhodanine as dual COX-1/2 and 5-LOX inhibitors: Synthesis, biological evaluation and docking study.
El-Miligy MMM; Hazzaa AA; El-Messmary H; Nassra RA; El-Hawash SAM
Bioorg Chem; 2017 Jun; 72():102-115. PubMed ID: 28390993
[TBL] [Abstract][Full Text] [Related]
15. Natural Inhibitors against Potential Targets of Cyclooxygenase, Lipoxygenase and Leukotrienes.
Dey R; Dey S; Samadder A; Saxena AK; Nandi S
Comb Chem High Throughput Screen; 2022; 25(14):2341-2357. PubMed ID: 34533441
[TBL] [Abstract][Full Text] [Related]
16. New benzothiophene derivatives as dual COX-1/2 and 5-LOX inhibitors: synthesis, biological evaluation and docking study.
El-Miligy MM; Hazzaa AA; El-Messmary H; Nassra RA; El-Hawash SA
Future Med Chem; 2017 Apr; 9(5):443-468. PubMed ID: 28362117
[TBL] [Abstract][Full Text] [Related]
17. Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade.
Tavolari S; Bonafè M; Marini M; Ferreri C; Bartolini G; Brighenti E; Manara S; Tomasi V; Laufer S; Guarnieri T
Carcinogenesis; 2008 Feb; 29(2):371-80. PubMed ID: 18033773
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological evaluation and molecular docking of new di-tert-butylphenol compound, LQFM-091, a new dual 5-LOX/COX inhibitor.
Lino RC; da Silva DPB; Florentino IF; da Silva DM; Martins JLR; Batista DDC; Leite KCS; Villavicencio B; Vasconcelos GA; Silva ALP; de Ávila RI; Verli H; Valadares MC; Gil ES; Vaz BG; Lião LM; Menegatti R; Costa EA
Eur J Pharm Sci; 2017 Aug; 106():231-243. PubMed ID: 28599988
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of celecoxib analogs that possess a N-hydroxypyrid-2(1H)one 5-lipoxygenase pharmacophore: biological evaluation as dual inhibitors of cyclooxygenases and 5-lipoxygenase with anti-inflammatory activity.
Chowdhury MA; Abdellatif KR; Dong Y; Das D; Suresh MR; Knaus EE
Bioorg Med Chem Lett; 2008 Dec; 18(23):6138-41. PubMed ID: 18945614
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs).
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2006 Dec; 14(23):7898-909. PubMed ID: 16904331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
